The Gateway to Algorithmic and Automated Trading

Omgeo and Enfusion partner to automate ETD post-trade processing

First Published 5th March 2013

Omgeo and Enfusion team on automating exchange-traded derivatives post-trade processes for hedge fund traders

Ted Leveroni, executive director of derivative strategy and external relations, Omgeo

Ted Leveroni, executive director of derivative strategy and external relations, Omgeo

"This new joint offering highlights Omgeo's aim to facilitate efficiency across the evolving global markets, increasing the use of best practice automation and lowering risk for buy- and sell-side firms alike."

Omgeo, the post trade services provider, has announced a business partnership with Enfusion, a provider of hosted portfolio management solutions for hedge funds and alternative investment firms, to offer their clients a joint solution connecting Enfusion's platform, Integrata, with Omgeo Central Trade Manager (Omgeo CTM).

Omgeo CTM is a strategic platform for the central matching of domestic and cross-border exchange-traded derivatives (ETDs), contracts for difference, equities and fixed income transactions.

The Omgeo and Enfusion joint solution automates ETD post-trade processes for the hedge fund industry, enabling clients to access the central matching benefits of Omgeo CTM directly from their Integrata portfolio management interface. With this offering, users can standardize post-trade workflows and enhance straight-through processing (STP) of ETD trades.

Tarek Hammoud, managing partner at Enfusion, said: "Our clients are moving toward more integrated workflows in post-trade operations, and many continue to express an interest in this new solution. Partnering with Omgeo is a logical step as it allows us to assist our clients to increase efficiencies in the processing of listed derivatives and reduce operational risks."

Ted Leveroni, executive director of derivative strategy and external relations at Omgeo, said: "As hedge funds continue to boost their trading strategies with listed derivatives, they need to ensure their middle- and back-office processes keep pace with their front-office activities. This new joint offering highlights Omgeo's aim to facilitate efficiency across the evolving global markets, increasing the use of best practice automation and lowering risk for buy- and sell-side firms alike."